Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Z-WAV is a medical technology company focused on developing a non-invasive, non-thermal, and non-ionizing therapeutic platform for the treatment of cancer. The company's proprietary Z-WAV technology utilizes specific wave patterns to selectively target and disrupt cancer cells while sparing healthy tissue. By leveraging mechanical forces rather than heat or radiation, Z-WAV aims to provide a safer and more effective alternative to traditional oncology treatments. The platform is currently being evaluated in pre-clinical models for various solid tumor indications, including pancreatic and breast cancer. Z-WAV's mission is to transform cancer care through innovative wave-based therapies that improve patient outcomes and quality of life.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Z-Wave.